Open AccessCitrate 4% versus Heparin and the Reduction of Thrombosis Study (CHARTS)
Author(s) -
Jennifer M. MacRae,
Ivana Dojcinovic,
Ognjenka Djurdjev,
Beverly Jung,
Steven Shalansky,
Adeera Levin,
Mercedeh Kiaii
Publication year - 2008
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01760407
Subject(s) - medicine , heparin , thrombosis , reduction (mathematics) , intensive care medicine , cardiology , mathematics , geometry
Citrate 4% has antithrombotic and antibacterial properties, which makes it a potentially superior alternative to heparin as an indwelling intraluminal locking agent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom